These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 22537242)

  • 1. Runx2 mediates epigenetic silencing of the bone morphogenetic protein-3B (BMP-3B/GDF10) in lung cancer cells.
    Tandon M; Gokul K; Ali SA; Chen Z; Lian J; Stein GS; Pratap J
    Mol Cancer; 2012 Jun; 11():27. PubMed ID: 22537242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone morphogenetic protein-3b (BMP-3b) inhibits osteoblast differentiation via Smad2/3 pathway by counteracting Smad1/5/8 signaling.
    Matsumoto Y; Otsuka F; Hino J; Miyoshi T; Takano M; Miyazato M; Makino H; Kangawa K
    Mol Cell Endocrinol; 2012 Mar; 350(1):78-86. PubMed ID: 22155034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lung tumor-associated osteoblast-derived bone morphogenetic protein-2 increased epithelial-to-mesenchymal transition of cancer by Runx2/Snail signaling pathway.
    Hsu YL; Huang MS; Yang CJ; Hung JY; Wu LY; Kuo PL
    J Biol Chem; 2011 Oct; 286(43):37335-46. PubMed ID: 21885439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of RUNX2 transcription factor in epithelial mesenchymal transition in non-small cell lung cancer lung cancer: Epigenetic control of the RUNX2 P1 promoter.
    Herreño AM; Ramírez AC; Chaparro VP; Fernandez MJ; Cañas A; Morantes CF; Moreno OM; Brugés RE; Mejía JA; Bustos FJ; Montecino M; Rojas AP
    Tumour Biol; 2019 May; 41(5):1010428319851014. PubMed ID: 31109257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plant homeodomain finger protein 2 promotes bone formation by demethylating and activating Runx2 for osteoblast differentiation.
    Kim HJ; Park JW; Lee KH; Yoon H; Shin DH; Ju UI; Seok SH; Lim SH; Lee ZH; Kim HH; Chun YS
    Cell Res; 2014 Oct; 24(10):1231-49. PubMed ID: 25257467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WWOX inhibits the invasion of lung cancer cells by downregulating RUNX2.
    Zheng QW; Zhou YL; You QJ; Shou F; Pang QF; Chen JL
    Cancer Gene Ther; 2016 Dec; 23(12):433-438. PubMed ID: 27834355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone morphogenetic protein-2 suppresses collagenase-3 promoter activity in osteoblasts through a runt domain factor 2 binding site.
    Varghese S; Rydziel S; Canalis E
    J Cell Physiol; 2005 Feb; 202(2):391-9. PubMed ID: 15389594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroid Hormone Receptor-β (TRβ) Mediates Runt-Related Transcription Factor 2 (Runx2) Expression in Thyroid Cancer Cells: A Novel Signaling Pathway in Thyroid Cancer.
    Carr FE; Tai PW; Barnum MS; Gillis NE; Evans KG; Taber TH; White JH; Tomczak JA; Jaworski DM; Zaidi SK; Lian JB; Stein JL; Stein GS
    Endocrinology; 2016 Aug; 157(8):3278-92. PubMed ID: 27253998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BMP signaling is required for RUNX2-dependent induction of the osteoblast phenotype.
    Phimphilai M; Zhao Z; Boules H; Roca H; Franceschi RT
    J Bone Miner Res; 2006 Apr; 21(4):637-46. PubMed ID: 16598384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dlx5 specifically regulates Runx2 type II expression by binding to homeodomain-response elements in the Runx2 distal promoter.
    Lee MH; Kim YJ; Yoon WJ; Kim JI; Kim BG; Hwang YS; Wozney JM; Chi XZ; Bae SC; Choi KY; Cho JY; Choi JY; Ryoo HM
    J Biol Chem; 2005 Oct; 280(42):35579-87. PubMed ID: 16115867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Runt-related transcription factor 2 (RUNX2) inhibits p53-dependent apoptosis through the collaboration with HDAC6 in response to DNA damage.
    Ozaki T; Wu D; Sugimoto H; Nagase H; Nakagawara A
    Cell Death Dis; 2013 Apr; 4(4):e610. PubMed ID: 23618908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone deacetylase inhibitor trichostatin A promotes the osteogenic differentiation of rat adipose-derived stem cells by altering the epigenetic modifications on Runx2 promoter in a BMP signaling-dependent manner.
    Hu X; Zhang X; Dai L; Zhu J; Jia Z; Wang W; Zhou C; Ao Y
    Stem Cells Dev; 2013 Jan; 22(2):248-55. PubMed ID: 22873791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of bone morphogenetic protein-2 and transforming growth factor beta1 on gene expression of transcription factors, AJ18 and Runx2 in cultured osteoblastic cells.
    Takagi M; Kamiya N; Takahashi T; Ito S; Hasegawa M; Suzuki N; Nakanishi K
    J Mol Histol; 2004 Jan; 35(1):81-90. PubMed ID: 15323353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone morphogenetic protein 2 activates Smad6 gene transcription through bone-specific transcription factor Runx2.
    Wang Q; Wei X; Zhu T; Zhang M; Shen R; Xing L; O'Keefe RJ; Chen D
    J Biol Chem; 2007 Apr; 282(14):10742-8. PubMed ID: 17215250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory roles of Runx2 in metastatic tumor and cancer cell interactions with bone.
    Pratap J; Lian JB; Javed A; Barnes GL; van Wijnen AJ; Stein JL; Stein GS
    Cancer Metastasis Rev; 2006 Dec; 25(4):589-600. PubMed ID: 17165130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metastatic breast cancer cells inhibit osteoblast differentiation through the Runx2/CBFβ-dependent expression of the Wnt antagonist, sclerostin.
    Mendoza-Villanueva D; Zeef L; Shore P
    Breast Cancer Res; 2011 Oct; 13(5):R106. PubMed ID: 22032690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone morphogenetic protein 3B silencing in non-small-cell lung cancer.
    Dai Z; Popkie AP; Zhu WG; Timmers CD; Raval A; Tannehill-Gregg S; Morrison CD; Auer H; Kratzke RA; Niehans G; Amatschek S; Sommergruber W; Leone GW; Rosol T; Otterson GA; Plass C
    Oncogene; 2004 Apr; 23(20):3521-9. PubMed ID: 15116090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Htra1 is a Novel Transcriptional Target of RUNX2 That Promotes Osteogenic Differentiation.
    Iyyanar PPR; Thangaraj MP; Eames BF; Nazarali AJ
    Cell Physiol Biochem; 2019; 53(5):832-850. PubMed ID: 31703162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of Runx2 signaling by TNF-α in ST2 murine bone marrow stromal cells undergoing osteogenic differentiation.
    Ye X; Huang H; Zhao N; Zhang J; Yang P
    In Vitro Cell Dev Biol Anim; 2016 Dec; 52(10):1026-1033. PubMed ID: 27401008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 gene expression.
    Gaur T; Lengner CJ; Hovhannisyan H; Bhat RA; Bodine PV; Komm BS; Javed A; van Wijnen AJ; Stein JL; Stein GS; Lian JB
    J Biol Chem; 2005 Sep; 280(39):33132-40. PubMed ID: 16043491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.